Cross-Sector entity
regulation is the sole category represented across all 2 tracked stories. Brookings Institution is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. Each carries 3 original sources on average. We currently track 2 Cross-Sector stories that mention Active Pharmaceutical Ingredients (APIs), all published on March 19, 2026.
2 verified stories tracked
Last mentioned: Mar 19, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
regulation is the sole category represented across all 2 tracked stories. Brookings Institution is the most frequent co-covered peer, appearing in 2 of the 2 tracked stories. Each carries 3 original sources on average. We currently track 2 Cross-Sector stories that mention Active Pharmaceutical Ingredients (APIs), all published on March 19, 2026.
Computed from the 2 stories linked to this entity. Beat comparisons are omitted because no baseline was available for this window.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Active Pharmaceutical Ingredients (APIs). Shared-story counts are live from our verified record — not editorial picks.
A high-profile House Select Committee hearing has highlighted the United States' critical dependence on Chinese active pharmaceutical ingredients (APIs). Lawmakers warn that Beijing is applying its successful industrial playbook from rare earths and EVs to corner the global medicine market, with Chinese pharma revenue projected to hit $2.1 trillion by 2030.
US lawmakers are raising alarms over the pharmaceutical industry's reliance on Chinese ingredients, warning that Beijing is applying its 'rare earths playbook' to dominate global medicine. A House Select Committee hearing highlighted concerns that China's control over active pharmaceutical ingredients and the biotech pipeline poses a strategic threat to American healthcare security.
